REQUEST A DEMO
Total
USD $0.00
Search more companies

Teva Pharma EAD (Bulgaria)

Main Activities: Pharmaceutical Preparation Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Teva Pharma EAD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Bulgaria's largest pharmaceuticals group Actavis AD, former Balkanpharma Holding, is active in the development, manufacture and sale of generic pharmaceuticals, diagnostics and other healthcare products. It produces some 300 pharmaceutical products and is one of the largest companies within the Icelandic generic drug group Actavis, former Pharmaco.
In December 2000, Pharmaco acquired Balkanpharma Holding, which owned controlling interests in three local drug plants - Balkanpharma-Dupnitsa, which focuses on solid dose drugs, Balkanpharma-Razgrad - specialised in antibiotics, and Balkanpharma-Troyan that produces liquid drugs only. Actavis Operations is in charge of management of production and investment in the drug-making plants in Dupnitsa, Troyan and Razgrad.

Headquarters
ul. Lyuba Velichkova 9
Sofia; Sofia - city; Postal Code: 1407

Contact Details: Purchase the Teva Pharma EAD report to view the information.

Website: https://www.teva.bg/

Basic Information
Total Employees:
Purchase the Teva Pharma EAD report to view the information.
Outstanding Shares:
Purchase the Teva Pharma EAD report to view the information.
Registered Capital:
Purchase the Teva Pharma EAD report to view the information.
Financial Auditors:
Purchase the Teva Pharma EAD report to view the information.
Incorporation Date:
May 27, 1993
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Balkanpharma Troyan AD
98.32%
Balkanpharma Dupnitsa AD
98.05%
Company Performance
Financial values in the chart are available after Teva Pharma EAD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
6.08%
Total operating revenue
6.23%
Operating profit (EBIT)
7.37%
EBITDA
13.83%
Net Profit (Loss) for the Period
5.88%
Total assets
10.77%
Total equity
11.15%
Operating Profit Margin (ROS)
0.17%
Net Profit Margin
-0.02%
Return on Equity (ROE)
-0.49%
Quick Ratio
0.1%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?